Lingohr & Partner Asset Management Gmb H Collegium Pharmaceutical, Inc Transaction History
Lingohr & Partner Asset Management Gmb H
- $57.3 Million
- Q3 2025
A detailed history of Lingohr & Partner Asset Management Gmb H transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Lingohr & Partner Asset Management Gmb H holds 5,871 shares of COLL stock, worth $209,946. This represents 0.36% of its overall portfolio holdings.
Number of Shares
5,871
Previous 5,871
-0.0%
Holding current value
$209,946
Previous $205,000
-0.0%
% of portfolio
0.36%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding COLL
# of Institutions
238Shares Held
35.7MCall Options Held
52.5KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$207 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.16MShares$113 Million2.15% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$94.5 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$80.4 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.58MShares$56.7 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.22B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...